Literature DB >> 27175270

Insights into the pathophysiology and therapy of myeloproliferative neoplasms from mouse models.

R A Van Etten1.   

Abstract

Entities:  

Keywords:  IKZF1 mutation; Ikaros; PPR mice; STAT5; TKI resistance; mouse models of CML

Year:  2014        PMID： 27175270      PMCID： PMC4851286          DOI： 10.1038/leusup.2014.15

Source DB:  PubMed          Journal:  Leuk Suppl        ISSN： 2044-5210


× No keyword cloud information.
  24 in total

1.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

Authors:  C S Huettner; P Zhang; R A Van Etten; D G Tenen
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

3.  JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.

Authors:  Sven Schwemmers; Britta Will; Cornelius F Waller; Khadija Abdulkarim; Peter Johansson; Björn Andreasson; Heike L Pahl
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

4.  Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.

Authors:  Steffen Koschmieder; Berthold Göttgens; Pu Zhang; Junko Iwasaki-Arai; Koichi Akashi; Jeffery L Kutok; Tajhal Dayaram; Kristin Geary; Anthony R Green; Daniel G Tenen; Claudia S Huettner
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

5.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

6.  Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures.

Authors:  R S Taichman; M J Reilly; S G Emerson
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

7.  Adoptive immunotherapy of BCR-ABL-induced chronic myeloid leukemia-like myeloproliferative disease in a murine model.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

8.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

9.  Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.

Authors:  Ila Joshi; Toshimi Yoshida; Nilamani Jena; Xiaoqing Qi; Jiangwen Zhang; Richard A Van Etten; Katia Georgopoulos
Journal:  Nat Immunol       Date:  2014-02-09       Impact factor: 25.606

10.  Differential regulation of myeloid leukemias by the bone marrow microenvironment.

Authors:  Daniela S Krause; Keertik Fulzele; André Catic; Chia Chi Sun; David Dombkowski; Michael P Hurley; Sanon Lezeau; Eyal Attar; Joy Y Wu; Herbert Y Lin; Paola Divieti-Pajevic; Robert P Hasserjian; Ernestina Schipani; Richard A Van Etten; David T Scadden
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.